GABAB receptor agonists reduce operant ethanol self-administration and enhance ethanol sedation in C57BL/6J mice
- 19 February 2004
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 174 (3) , 358-366
Abstract
A growing number of studies suggest that γ-aminobutyric acid type-B (GABAB) receptor agonists reduce alcohol use and craving. This study was designed to further clarify behavioral mechanism(s) by which GABAB agonists may decrease alcohol reinforcement. Male C57BL/6 J mice were trained to lever press on a concurrent schedule of ethanol (10% v/v) and water reinforcement during 16-h overnight sessions. Effects of the GABAB agonist baclofen (0–17 mg/kg, IP) or SKF 97541 (0–1 mg/kg, IP) were examined on parameters of self-administration. Subsequently, potential motor inhibition and interaction with ethanol-induced sedation by GABAB agonists was examined in ethanol naive and self-administering mice. Baclofen (10 mg/kg) and SKF 97541 (0.3 mg/kg) reduced ethanol-reinforced responding. In a locomotor activity test, these doses of the GABAB agonists inhibited locomotion in the ethanol-experienced mice and in a group of ethanol-inexperienced mice; locomotor suppression was greater in the ethanol-inexperienced mice. These doses of the GABAB agonists also potentiated the sedative effects of ethanol (4 g/kg) and converted a nonsedative dose of ethanol (2 g/kg) into a fully sedative dose. GABAB agonist enhancement of the sedative effects of ethanol was less pronounced in ethanol self-administering mice, suggesting cross-tolerance at the low dose of ethanol. GABAB agonists decrease the reinforcing effects of ethanol at doses that inhibit locomotor activity and potentiate the sedative hypnotic effects of ethanol. These nonspecific effects of GABAB agonists were reduced in alcohol experienced mice, suggesting cross-tolerance to the inhibitory properties of GABAB positive modulation. These data question the safety of prescribing GABAB agonists to alcoholics since these drugs may potentiate ethanol’s sedative/hypnotic effects during relapse.Keywords
This publication has 41 references indexed in Scilit:
- THE GABAB RECEPTOR AGONISTS BACLOFEN AND CGP 44532 PREVENT ACQUISITION OF ALCOHOL DRINKING BEHAVIOUR IN ALCOHOL-PREFERRING RATSAlcohol and Alcoholism, 2002
- GABAB receptor agonists for the treatment of drug addiction: a review of recent findingsDrug and Alcohol Dependence, 2002
- Benzodiazepine-GABA modulation of concurrent ethanol and sucrose reinforcement in the rat.Experimental and Clinical Psychopharmacology, 1997
- GABAergic Transmission in the Nucleus Accumbens Is Involved in the Termination of Ethanol Self‐Administration in RatsAlcohol, Clinical and Experimental Research, 1995
- Effects of acute and chronic ethanol treatment on pre- and postsynaptic responses to baclofen in rat hippocampusBrain Research, 1991
- Ethanol‐Induced Changes in Chloride Flux are Mediated by Both GABAA and GABAB ReceptorsAlcohol, Clinical and Experimental Research, 1991
- Mechanisms of general anesthesia: Brain regional ersponses to baclofenPhysiology & Behavior, 1989
- A new alcohol antagonist: PhaclofenLife Sciences, 1989
- Food intake suppressant effect of baclofen in ratsGeneral Pharmacology: The Vascular System, 1989
- GABAergic influences on defensive fighting in ratsPharmacology Biochemistry and Behavior, 1982